Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-14

Clinical Trial Update: Oral Bisoprolol Vs IV Diltiazem in Atrial Fibrillation or Flutter With Rapid Ventricular Rate. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing oral bisoprolol to IV diltiazem for rate control in atrial fibrillation or atrial flutter with rapid ventricular response; curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bisoprolol (Bisoprolol)
  • Diltiazem (diltiazem)

Snippet

Sponsor: Oman Medical Speciality Board | Conditions: Atrial Fibrillation With Rapid Ventricular Response, Atrial Flutter With Rapid Ventricular Response | Phase 3 | Status: NOT_YET_RECRUITING